There are many reports of the treatment of amyloidosis, in the medical literature. There are several biochemical types of amyloid and the response to therapy may vary, according to type and which organ in the body is affected. There are many descriptions of the response to therapy of gastrointestinal amyloid, but fewer of response to therapy of pulmonary amyloid. Pulmonary amyloid has responded to treatment with melphalen and corticosteroids. Also pulmonary amyloidosis, associated with rheumatoid arthritis, has responded to a combination of methotrexate and Remicade® (infliximab).
For further assistance, you might want to visit the National Institutes of Health (NIH) website at, http://www.nih.gov/.